Progress in sulfonamide hypersensitivity and cross-hypersensitivity

XU Hui-min,CAI Hong-wen,LI Tian-yuan,WEI Er-qing
DOI: https://doi.org/10.3867/j.issn.1000-3002.2012.06.021
2012-01-01
Abstract:A sulfonamide is any compound with an-SO2NH2 moiety.The clinical significance of cross-reactivity of medications in a person with a "sulfa" allergy continues to perplex clinicians and complicates decisions regarding patient safety.Patients with hypersensitivity to sulfonamide antibacterials are not rare.The manufacturer′s package inserts of different sulfonamides about concerning use in patients with a sulfonamide allergy are not consistent.There are no standard procedures or guidelines for the cautious administration of other sulfonamide-containing medications for patients hypersensitive to sulfonamide antibacterial.In this paper,we reviewed the etiology of sulfonamide antibacterial hypersensitivity.The major differences between sulfonamide antibacterials and other sulfonamide-containing medications(such as furosemide,thiazide diuretics and celecoxib) are that sulfonamide antibacterials contain an aromatic amine group at the N4 position and a heterocyclic ring at N1 position.These differences are considered to be critical in the development of hypersensitivity reactions to sulfonamide antibacterials.Cross-hypersensitivity between sulfonamide antibacterials and other sulfonamide-containing medications would not be expected to occur based on their chemical differences.The clinical data about sulfonamide cross-hypersensitivity were also reviewed.A retrospective cohort study has indicated that patients allergic to sulfonamide bacterials seem to be more likely to react to sulfonamide non-antibacterials than non-allergic patients.However,this high risk of allergic reactions appears to be due to a predisposition to allergic reactions rather than to cross-hypers ensitivity with sulfonamide-base drugs.From the evidence acquired,neither scientific evidence nor clinical research is enough to support the cross-hypersensitivity between sulfonamide bacterials and other sulfonamide-containing medications.Since a history of allergic reactions to sulfonamide bacterials may be at increased risk for other medications,whether other sulfonamide-containing medications can be used for patients with sulfonamide antibacterial allergy should depend on the contents of manufactures package inserts of sulfonamides,severity of the initial allergy and the presence of available alternatives.
What problem does this paper attempt to address?